Maltose

SCHEMBL9704098

O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O.[K]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1A ADRA1B ADRA1D ADRA2A ADRA2B ADRA2C ADRB1 ADRB2 ADRB3 CALCRL CHRM1 CHRM2 CHRM3 F2R MAOA MAOB MAP2K1 MAP2K2 NTRK1 NTRK2 NTRK3 OPRD1 OPRK1 OPRM1 P2RY12 PKLR SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SLC18A2 SLC6A2 SLC6A3 TLR7 TLR9 TUBA1A TUBA1B TUBA1C TUBA3C TUBA3E TUBA4A TUBB TUBB1 TUBB2A TUBB2B TUBB3 TUBB4A TUBB4B TUBB6 TUBB8 dacA dacB dacC folA ftsI mrcA mrcB mrdA pol rplA rplB rplC rplD rplE rplF rplI rplJ rplK rplL rplM rplN rplO rplP rplQ rplR rplS rplT rplU rplV rplW rplX rplY rpmA rpmB rpmB1 rpmB2 rpmC rpmD rpmE rpmE2 rpmF rpmG rpmG1 rpmG2 rpmH rpmI rpmJ rpmJ2 rpsA rpsB rpsC rpsD rpsE rpsF rpsG rpsH rpsI rpsJ rpsK rpsL rpsM rpsN rpsO rpsP rpsQ rpsR rpsR1 rpsR2 rpsS rpsT rpsU rpsZ ykgM ykgO

The experimentally established mechanism targets of Maltose. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

	gene	UniProt	supporting neighbours	confidence
▸	LGALS8	O00214	1/20	0.53

▸	LGALS3	P17931	1/20	0.53

▸	LGALS4	P56470	1/20	0.53

▸	MAPT	P10636	1/20	0.53

▸	BLM	P54132	1/20	0.50

▸	RECQL	P46063	1/20	0.50

▸	TDP1	Q9NUW8	1/20	0.50

▸	CA12	O43570	8/20	0.48

▸	CA1	P00915	8/20	0.48

▸	CA2	P00918	8/20	0.48

▸	CA9	Q16790	8/20	0.48

▸	AMY2A	P04746	2/20	0.48

▸	MEN1	O00255	1/20	0.48

▸	KMT2A	Q03164	1/20	0.48

▸	CA14	Q9ULX7	4/20	0.47

▸	IGF2R	P11717	1/20	0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
Cellobiose SCHEMBL4761241	0.98	LGALS8 (0.54)	LGALS8LGALS3LGALS4MAPTBLM
Cellobiose SCHEMBL31280904	0.92	LGALS8 (0.59)	LGALS8LGALS3LGALS4AMY2AMEN1
Sulfuric Acid SCHEMBL8756855	0.91	MAPT (0.55)	LGALS8LGALS3LGALS4MAPTBLM
Cellobiose SCHEMBL23708014	0.91	LGALS8 (0.61)	LGALS8LGALS3LGALS4AMY2AMEN1
Maltotriose SCHEMBL24202675	0.91	LGALS8 (0.61)	LGALS8LGALS3LGALS4AMY2AMEN1
Cellobiose SCHEMBL23752618	0.91	LGALS8 (0.61)	LGALS8LGALS3LGALS4AMY2AMEN1
Cellobiose SCHEMBL24662526	0.91	LGALS8 (0.61)	LGALS8LGALS3LGALS4AMY2AMEN1
Maltotriose SCHEMBL20840281	0.91	LGALS8 (0.61)	LGALS8LGALS3LGALS4AMY2AMEN1
SCHEMBL21752778	0.91	LGALS8 (0.61)	LGALS8LGALS3LGALS4AMY2AMEN1
Cellobiose SCHEMBL21206262	0.91	LGALS8 (0.61)	LGALS8LGALS3LGALS4AMY2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-0230023-B1	PHARMACEUTICAL COMPOSITIONS FOR THE ENHANCEMENT OF WOUND HEALING	MARION MERRELL DOW INC. (US)	1992-09-02	—	—	EP	disclosed
US-4912093-A	Polysulfated (mono- or oligo-)saccharide	MARION LABORATORIES, INC. (US)	1990-03-27	—	—	US	disclosed
EP-0230023-A2	Pharmaceutical compositions for the enhancement of wound healing	MARION MERRELL DOW INC. (US)	1987-07-29	—	—	EP	disclosed